Pat Killingsworth's Archive

Pat Killingsworth wrote a regular column for The Myeloma Beacon from April, 2010 to February, 2016. He was diagnosed with multiple myeloma in April, 2007 at the age of 51. He initially achieved a complete response to treatment with a combination of extensive radiation and continuous drug-based therapy. Four years after his diagnosis, Pat's disease returned, and he underwent a series of additional treatments, including a total of three autologous stem cell transplants at different times. Unfortunately, Pat passed away on his 60th birthday in February, 2016. By that time, however, Pat had made a significant impact on the lives of many patients and caregivers through his extensive writing and speaking about multiple myeloma. Pat's efforts were supported and made possible in many ways by his wife Pattie, who is also a cancer survivor, and is still cancer-free today.

Pat Killingsworth has written 140 article(s) .

[ by | Jun 15, 2010 4:11 pm | 5 Comments ]
Management Of Nerve Damage In Myeloma Patients (ASCO 2010)

Many multiple myeloma patients are afflicted by tingling and pain in the hands, arms, feet, and legs (known as peripheral neuropathy). Treatments for myeloma can make this neuropathy worse. Dr. Paul Richardson of the Dana-Farber Cancer Institute discussed the prevention and management of peripheral neuropathy (PN) during an education session on June 7 at the annual American Society of Clinical Oncology (ASCO) meeting.

Dr. Richardson explained that myeloma, itself, causes nerve damage that leads to the pain and tingling. Up …

Tags: , , , ,
Read the full story »
[ by | Jun 14, 2010 4:23 pm | One Comment ]
Prevention Of Blood Clots In Myeloma Patients Is Important (ASCO 2010)

Multiple myeloma patients are at an increased risk of developing deep vein blood clots, and several myeloma treatments further increase the risk. However, blood clots can often be prevented with the use of blood thinners, according to Dr. Todd Zimmerman of the University of Chicago during a myeloma education session on June 7 at the annual American Society of Clinical Oncology (ASCO) meeting.

Dr. Zimmerman reported that there is a nine-fold increase of deep vein thrombosis (a blood clot in …

Tags: , , ,
Read the full story »
[ by | Jun 10, 2010 11:50 am | 44 Comments ]
Pat's Place: Having Multiple Myeloma Isn't Simple — It's Hard!

Having multiple myeloma isn't simple – It's hard! Not only do you have cancer, but you also have a dizzying array of treatment options available to you. Additionally, it doesn’t just affect your health–it can affect just about all aspects of your life.

First, you and your caregiver need to decide where to go for treatment. Do you travel across state lines to a large, regional or national cancer center that specializes in treating myeloma? Or do …

Tags: , , ,
Read the full story »
[ by and | Jun 8, 2010 5:01 pm | Comments Off ]
ASCO 2010 Multiple Myeloma Update – Day Four

Yesterday was the fourth day of the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Although today is the final day of the meeting, the multiple myeloma-related sessions concluded yesterday.

The day began with a meeting-wide session to review the highlights of the previous day across all cancer types. There were six presentations, and despite all of the types of cancers being discussed at the meeting, an entire presentation was devoted to myeloma.

Dr. Jean-Luc Harousseau from the …

Tags: , , , , , , , , , , , ,
Read the full story »
[ by and | Jun 7, 2010 6:26 pm | 3 Comments ]
ASCO 2010 Multiple Myeloma Update – Day Three

The third day of the American Society of Clinical Oncology (ASCO) 2010 annual meeting in Chicago was tailor-made for morn­ing people interested in mul­ti­ple myeloma.  The key myeloma-related activity on Sunday, June 6 was a morn­ing abstract session start­ing at 9:30 a.m.  Nine abstracts were pre­sented and discussed over the course of three hours.

The first two pre­sen­ta­tions dealt with Velcade (bor­tez­o­mib)-related re­search.

Dr. Antonio Palumbo of the Uni­ver­sity of Turin pre­sented the re­­sults of the first study.  It com­pared two regi­mens for …

Tags: , , , , , , , , , , , , , , , , ,
Read the full story »
[ by and | Jun 6, 2010 6:39 pm | Comments Off ]
ASCO 2010 Multiple Myeloma Update – Day Two

Yesterday -- Saturday, June 5 -- was the sec­ond day of the American Society of Clinical Oncology (ASCO) 2010 annual meeting in Chicago.  It was a busy day in terms of re­search posters and pre­sen­ta­tions re­lated to mul­ti­ple myeloma.  As a re­­sult, there is a lot of ground to cover in this up­date.

Almost 40 myeloma-related posters were up for meeting attendees to view during the daytime poster session on "lymphoma and plasma cell disorders."  Among those 40-or-so posters, six con­cerned re­search done by …

Tags: , , , , , , , , , , , , , , , , , , , ,
Read the full story »
[ by | Jun 5, 2010 3:55 pm | Comments Off ]
ASCO 2010 Multiple Myeloma Update - Day One

Friday, June 4, was the first day of this year's American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Most of the big multiple myeloma news of the day came out of a poster session in the afternoon.

At "poster sessions," researchers present a poster-sized summary of their research in a small, 2 meter by 1 meter cubicle. Researchers and physicians mill about, taking pictures of the posters with their cell phone cameras or taking notes. Sometimes one or more …

Tags: , , , , , , , , , , , , ,
Read the full story »